TP53 and lung carcinoma: The lung cancer cohort consisted of up to 79 patient samples, also utilized in a previous study analyzing the effects of p53 codon 72 polymorphism and MDM SNP309, which found no significant association of the codon 72 SNP with lung cancer susceptibility in female [34].